PRA Adds Large Molecule Capabilities to US Laboratory
PRA announced the addition of capabilities and services to its Lenexa, KS location.
PRA, a clinical research organization, announced the addition of capabilities and services to its Lenexa, KS location. Now, in addition to the laboratory in Assen, The Netherlands offering full-service bioanalytical capabilities, the Lenexa, KS laboratory will now offer immunochemistry services. The additions solidify PRA as the only company in the world with full-service bioanalytical capabilities near its clinics to support rapid results from Phase I clinical studies in the US and Europe.
Read the full release here.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
